Tuttiquotidiani is completely free. Every day we aggregate news from 100+ sources and generate original AI summaries for you. Help us keep the service running with a small donation, or become TQ Pro for just €1/month.

Donate now TQ Pro - 1€/mo

‘My bladder is scarred. This is a substance far from harmless’

Ketamine abuse among adolescents and young adults has emerged as a significant public health concern, with emerging epidemiological data hig...

Kushner and Witkoff’s blind amateurism

Financial Times

September 9, 2026

FNZ: the Credit Suisse spinout haemorrhaging cash

Financial Times

September 7, 2026

Why schools should stop banning peanuts

Washington Post

September 8, 2026

Big banks allegedly defrauded of $500m by Penthouse Syndicate

The Sydney Morning Herald

September 9, 2026

Biolife granted U.S. patent for novel effervescent oral peptide delivery technology

Posted on September 11, 2026
By Google News
0 Views
1 min read

In brief

Generating AI summary…

Biolife granted U.S. patent for novel effervescent oral peptide delivery technology

BioLife today announced that the United States Patent and Trademark Office has granted U.S. Patent 12,667,605 B2 for its novel effervescent oral peptide delivery technology, designed to support current and future peptide therapeutics for obesity, diabetes and metabolic disease.